RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 137 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 16.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $5,445 | -16.4% | 1,500 | 0.0% | 0.00% | – |
Q2 2021 | $6,510 | +26.9% | 1,500 | 0.0% | 0.00% | – |
Q1 2021 | $5,130 | -2.3% | 1,500 | 0.0% | 0.00% | – |
Q4 2020 | $5,250 | +45.8% | 1,500 | 0.0% | 0.00% | – |
Q3 2020 | $3,600 | +31.1% | 1,500 | 0.0% | 0.00% | – |
Q2 2020 | $2,745 | +17.3% | 1,500 | 0.0% | 0.00% | – |
Q1 2020 | $2,340 | -27.1% | 1,500 | 0.0% | 0.00% | – |
Q4 2019 | $3,210 | +14.4% | 1,500 | 0.0% | 0.00% | – |
Q3 2019 | $2,805 | -28.4% | 1,500 | 0.0% | 0.00% | – |
Q2 2019 | $3,915 | +1.6% | 1,500 | 0.0% | 0.00% | – |
Q1 2019 | $3,855 | +11.7% | 1,500 | 0.0% | 0.00% | – |
Q4 2018 | $3,450 | -28.3% | 1,500 | 0.0% | 0.00% | -100.0% |
Q3 2018 | $4,815 | +13.4% | 1,500 | 0.0% | 0.00% | – |
Q2 2018 | $4,245 | -20.1% | 1,500 | 0.0% | 0.00% | -100.0% |
Q1 2018 | $5,310 | -8.8% | 1,500 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $5,820 | +52.8% | 1,500 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $3,810 | – | 1,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Advisers, LP | 8,350,000 | $28,557,000 | 5.86% |
Ion Asset Management Ltd. | 3,632,132 | $12,422,000 | 1.43% |
CM Management, LLC | 500,000 | $1,710,000 | 1.27% |
SECTOR GAMMA AS | 1,530,490 | $5,234,000 | 0.96% |
Rhenman & Partners Asset Management AB | 1,520,000 | $5,198,000 | 0.36% |
Rock Springs Capital Management LP | 4,742,000 | $16,218,000 | 0.35% |
Telemetry Investments, L.L.C. | 90,000 | $308,000 | 0.35% |
DAFNA Capital Management LLC | 275,500 | $942,000 | 0.22% |
KELLEHER FINANCIAL ADVISORS | 100,000 | $342,000 | 0.22% |
Virtus ETF Advisers LLC | 91,971 | $315,000 | 0.13% |